CLINICAL_TRIALS
trial_result
· 2019-12-20
Clinical Trial Update: Effects of RP101 in Post-menopausal Women With Dry Eye Syndrome [Phase 2]
Summary
Phase 2 clinical trial update evaluating RP101 in post-menopausal women with dry eye syndrome has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Redwood Pharma AB | Conditions: Dry Eye Syndromes | Phase 2 | Status: COMPLETED